Article
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.
Proceedings of the National Academy of Sciences of the United States of America - 20 Jun 2017
Montero-Conde Cristina, Leandro-Garcia Luis J, Chen Xu, Oler Gisele, Ruiz-Llorente Sergio, Ryder Mabel, Landa Iñigo, Sanchez-Vega Francisco, La Konnor, Ghossein Ronald A, Bajorin Dean F, Knauf Jeffrey A, Riordan Jesse D, Dupuy Adam J, Fagin James A
Abstract excerpt
Oncogenic RAS mutations are present in 15-30% of thyroid carcinomas. Endogenous expression of mutant Ras is insufficient to initiate thyroid tumorigenesis in murine models, indicating that additional genetic alterations are required. We used Sleeping Beauty (SB) transposon mutagenesis to identify events that cooperate with HrasG12V in thyroid tumor development. Random genomic integration of SB transposons...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
